Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 5821369, 6 pages
https://doi.org/10.1155/2018/5821369
Research Article

Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study

1Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu 610041, China
2Pediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China
3Department of Child Health, West China Second University Hospital, Sichuan University, Chengdu 610041, China

Correspondence should be addressed to Yi Ji; moc.361@nauynauyijij

Received 9 September 2017; Revised 28 December 2017; Accepted 4 January 2018; Published 25 February 2018

Academic Editor: Jean Kanitakis

Copyright © 2018 Chuan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Hoeger, J. I. Harper, E. Baselga et al., “Treatment of infantile haemangiomas: recommendations of a European expert group,” European Journal of Pediatrics, vol. 174, no. 7, pp. 855–865, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Ji, S. Chen, B. Xiang et al., “Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study,” Scientific Reports, vol. 6, Article ID 31744, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Marqueling, V. Oza, I. J. Frieden, and K. B. Puttgen, “Propranolol and infantile hemangiomas four years later: a systematic review,” Pediatric Dermatology, vol. 30, no. 2, pp. 182–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. E. Cheng and S. F. Friedlander, “Infantile hemangiomas, complications and treatments,” Seminars in Cutaneous Medicine and Surgery, vol. 35, no. 3, pp. 108–116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Wood, K. Carr, R. Vestal, S. Belcher, G. Wilkinson, and D. Shand, “Direct measurement of propranolol bioavailability during accumulation to steady‐state.,” British Journal of Clinical Pharmacology, vol. 6, no. 4, pp. 345–350, 1978. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A Bryan, “Reconsidering the use of propranolol in the treatment of cosmetic infantile hemangiomas,” Angiology: Open Access, vol. 01, no. 01, 2013. View at Publisher · View at Google Scholar
  7. Y. Ji, S. Chen, K. Li, X. Xiao, S. Zheng, and T. Xu, “The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells,” Cell Division, vol. 8, no. 1, 2013, article no. 1. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Langley and E. Pope, “Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas,” British Journal of Dermatology, vol. 172, no. 1, pp. 13–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Mihov, S. Mayer, F. Musshoff, W. Maier, K. M. Kendrick, and R. Hurlemann, “Facilitation of learning by social-emotional feedback in humans is beta-noradrenergic-dependent,” Neuropsychologia, vol. 48, no. 10, pp. 3168–3172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Léaute-Labrèze, O. Boccara, C. Degrugillier-Chopinet et al., “Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review,” Pediatrics, vol. 138, no. 4, Article ID e20160353, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. R. H. Berger, A. L. Miller, R. Seifer, S. R. Cares, and M. K. Lebourgeois, “Acute sleep restriction effects on emotion responses in 30- to 36-month-old children,” Journal of Sleep Research, vol. 21, no. 3, pp. 235–246, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Dror, G. Malinger, L. Ben-Sira, D. Lev, C. G. Pick, and T. Lerman-Sagie, “Developmental outcome of children with enlargement of the Cisterna Magna identified in Utero,” Journal of Child Neurology, vol. 24, no. 12, pp. 1486–1492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Meinzen-Derr, S. Wiley, S. Grether, and D. I. Choo, “Children with cochlear implants and developmental disabilities: a language skills study with developmentally matched hearing peers,” Research in Developmental Disabilities, vol. 32, no. 2, pp. 757–767, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Munden, R. Butschek, W. L. Tom et al., “Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies,” British Journal of Dermatology, vol. 170, no. 4, pp. 907–913, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Cuccaro, A. Rapacciuolo, R. Vitiello et al., “Propranolol for severe hemangioma of infancy,” Journal of Cardiovascular Medicine, vol. 12, no. 1, p. 5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. H. Hoeger, “Propranolol for infantile haemangiomas: certain chances, potential risks,” British Journal of Dermatology, vol. 172, no. 1, pp. 3-4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Itoi, “Ablation of the central noradrenergic neurons for unraveling their roles in stress and anxiety,” Annals of the New York Academy of Sciences, vol. 1129, pp. 47–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Cahill, R. Babinsky, H. J. Markowitsch, and J. L. Mc Gaugh, “The amygdala and emotional memory,” Nature, vol. 377, no. 6547, pp. 295-296, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Cahill, B. Prins, M. Weber, and J. L. McGaugh, “β-Adrenergic activation and memory for emotional events,” Nature, vol. 371, no. 6499, pp. 702–704, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. B. A. Strange and R. J. Dolan, “β-Adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 101, no. 31, pp. 11454–11458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. E. Hayes and S. C. Schulz, “Beta-blockers in anxiety disorders,” Journal of Affective Disorders, vol. 13, no. 2, pp. 119–130, 1987. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Pitman, K. M. Sanders, R. M. Zusman et al., “Pilot study of secondary prevention of posttraumatic stress disorder with propranolol,” Biological Psychiatry, vol. 51, no. 2, pp. 189–192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Stoschitzky, A. Sakotnik, P. Lercher et al., “Influence of beta-blockers on melatonin release,” European Journal of Clinical Pharmacology, vol. 55, no. 2, pp. 111–115, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Hudon, J. Moise K.J., S. E. Hegemier et al., “Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease,” American Journal of Obstetrics & Gynecology, vol. 179, no. 4, pp. 858–863, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. W. D. Williamson, G. S. Wilson, M. H. Lifschitz, and S. A. Thurber, “Nonhandicapped very-low-birth-weight infants at one year of age: developmental profile,” Pediatrics, vol. 85, no. 3, pp. 405–410, 1990. View at Google Scholar · View at Scopus
  26. A. V. Moyakine, D. J. J. Hermans, J. Fuijkschot, and C. J. M. Van Der Vleuten, “Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development,” Journal of the American Academy of Dermatology, vol. 73, no. 2, pp. 341-342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. V. Moyakine, J. M. Kerstjens, S. Spillekom-Van Koulil, and C. J. M. Van Der Vleuten, “Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years,” Journal of the American Academy of Dermatology, vol. 75, no. 1, pp. 59–63.e1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. A. V. Moyakine, S. Spillekom-van Koulil, and C. J. M. van der Vleuten, “Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age,” Journal of the American Academy of Dermatology, vol. 77, no. 1, pp. 105–108, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Colletti, M. Carner, V. Miorelli, M. Guida, L. Colletti, and F. G. Fiorino, “Cochlear implantation at under 12 months: report on 10 patients,” The Laryngoscope, vol. 115, no. 3, pp. 445–449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Hurlemann, H. Walter, A. K. Rehme et al., “Human amygdala reactivity is diminished by the β-noradrenergic antagonist propranolol,” Psychological Medicine, vol. 40, no. 11, pp. 1839–1848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Cahill and A. Van Stegeren, “Sex-related impairment of memory for emotional events with β-adrenergic blockade,” Neurobiology of Learning and Memory, vol. 79, no. 1, pp. 81–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. S. D. Shah, E. Baselga, C. McCuaig et al., “Rebound growth of infantile hemangiomas after propranolol therapy,” Pediatrics, vol. 137, no. 4, Article ID e20151754, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Léauté-Labrèze, J. I. Harper, and P. H. Hoeger, “Infantile haemangioma,” The Lancet, vol. 390, no. 10089, pp. 85–94, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Przybyslawski and S. J. Sara, “Reconsolidation of memory after its reactivation,” Behavioural Brain Research, vol. 84, no. 1-2, pp. 241–246, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. L. C. Chang, A. N. Haggstrom, B. A. Drolet et al., “Growth characteristics of infantile hemangiomas: implications for management,” Pediatrics, vol. 122, no. 2, pp. 360–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Ji, S. Chen, C. Xu, L. Li, and B. Xiang, “The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action,” British Journal of Dermatology, vol. 172, no. 1, pp. 24–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Ji, S. Chen, B. Xiang, Y. Yang, and L. Qiu, “Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study,” Scientific Reports, vol. 7, no. 1, article no. 1503, 2017. View at Publisher · View at Google Scholar · View at Scopus